rsodeoxycholic acid in cholelithiasis
Not Applicable
- Conditions
- .
- Registration Number
- IRCT20120624010104N7
- Lead Sponsor
- Ahran Tejarat Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 24
Inclusion Criteria
Complete clinical health
Age 18 to 60 years
Male volunteers
Exclusion Criteria
Underlying diseases
Hypertension
Kidney
Liver and gastrointestinal diseases
Smoking and alcohol consumption
Chronic drug use
Temporary drug use less than 10 days after sampling
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of drug concentration in plasma. Timepoint: Blood sampling during 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 6, 8, 10, 24, 48, 72 hour after taking the drug. Method of measurement: UV-HPLC.
- Secondary Outcome Measures
Name Time Method Pharmacokinetic parameters. Timepoint: Immediately after the intervention. Method of measurement: Theoretically and using pharmacokinetic equations.